Changes in metabolic syndrome and metabolic parameters after changes in body weight for all groups combined (SMS+, SMS−, and CAU). Differences were tested with multilevel logistic regression analyses for categorical variables and with multilevel linear regression analyses for continuous variables, combined with a bootstrap procedure in case of a non-normal distribution.
. | Changes in body weight (all groups combined) . | ||||
---|---|---|---|---|---|
5% weight gain . | 5% weight loss . | 10% weight loss . | Estimate (s.e.) . | P value . | |
Metabolic syndrome (%) | 14.1 | −13.2 | −23.8 | 0.114 (0.028) | <0.001 |
Waist ≥ 88 cm (%) | 5.5 | −9.2 | −22.9 | 0.139 (0.033) | <0.001 |
Glucose ≥ 6.1 mmol/L (%) | 2.7 | −1.7 | −2.7 | 0.105 (0.061) | 0.090 |
BP ≥ 129/84 mmHg (%) | 6.9 | −6.1 | −11.4 | 0.061 (0.025) | 0.017 |
HDL < 1.3 mmol/L (%) | 1.4 | −1.9 | −4.4 | 0.066 (0.044) | 0.133 |
TG ≥ 1.7 mmol/L (%) | 5.5 | −4.9 | −9.0 | 0.054 (0.027) | 0.047 |
Insulin resistance (%) | 9.2 | −11.5 | −24.2 | 0.103 (0.025) | <0.001 |
Metabolic parameters | |||||
cMetS z-score | 0.22 | −0.22 | −0.43 | 0.043 (0.005) | <0.001 |
HOMA-IR | 0.42 | −0.42 | −0.83 | 0.083 (0.017) | <0.001 |
SBP (mmHg) | 2 | −2 | −4 | 0.373 (0.101) | 0.001 |
DBP (mmHg) | 2 | −2 | −3 | 0.333 (0.076) | <0.001 |
Waist (cm) | 4.1 | −4.1 | −8.3 | 0.827 (0.080) | <0.001 |
Glucose (mmol/L) | 0.1 | −0.1 | −0.2 | 0.015 (0.004) | 0.001 |
Insulin (pmol/L) | 11 | −11 | −22 | 2.187 (0.484) | <0.001 |
Cholesterol (mmol/L) | 0.1 | −0.1 | −0.2 | 0.022 (0.006) | 0.001 |
HDL (mmol/L) | −0.02 | 0.02 | 0.05 | −0.005 (0.002) | 0.006 |
LDL (mmol/L) | 0.08 | −0.08 | −0.17 | 0.017 (0.005) | 0.005 |
TG (mmol/L) | 0.12 | −0.12 | −0.23 | 0.023 (0.005) | <0.001 |
. | Changes in body weight (all groups combined) . | ||||
---|---|---|---|---|---|
5% weight gain . | 5% weight loss . | 10% weight loss . | Estimate (s.e.) . | P value . | |
Metabolic syndrome (%) | 14.1 | −13.2 | −23.8 | 0.114 (0.028) | <0.001 |
Waist ≥ 88 cm (%) | 5.5 | −9.2 | −22.9 | 0.139 (0.033) | <0.001 |
Glucose ≥ 6.1 mmol/L (%) | 2.7 | −1.7 | −2.7 | 0.105 (0.061) | 0.090 |
BP ≥ 129/84 mmHg (%) | 6.9 | −6.1 | −11.4 | 0.061 (0.025) | 0.017 |
HDL < 1.3 mmol/L (%) | 1.4 | −1.9 | −4.4 | 0.066 (0.044) | 0.133 |
TG ≥ 1.7 mmol/L (%) | 5.5 | −4.9 | −9.0 | 0.054 (0.027) | 0.047 |
Insulin resistance (%) | 9.2 | −11.5 | −24.2 | 0.103 (0.025) | <0.001 |
Metabolic parameters | |||||
cMetS z-score | 0.22 | −0.22 | −0.43 | 0.043 (0.005) | <0.001 |
HOMA-IR | 0.42 | −0.42 | −0.83 | 0.083 (0.017) | <0.001 |
SBP (mmHg) | 2 | −2 | −4 | 0.373 (0.101) | 0.001 |
DBP (mmHg) | 2 | −2 | −3 | 0.333 (0.076) | <0.001 |
Waist (cm) | 4.1 | −4.1 | −8.3 | 0.827 (0.080) | <0.001 |
Glucose (mmol/L) | 0.1 | −0.1 | −0.2 | 0.015 (0.004) | 0.001 |
Insulin (pmol/L) | 11 | −11 | −22 | 2.187 (0.484) | <0.001 |
Cholesterol (mmol/L) | 0.1 | −0.1 | −0.2 | 0.022 (0.006) | 0.001 |
HDL (mmol/L) | −0.02 | 0.02 | 0.05 | −0.005 (0.002) | 0.006 |
LDL (mmol/L) | 0.08 | −0.08 | −0.17 | 0.017 (0.005) | 0.005 |
TG (mmol/L) | 0.12 | −0.12 | −0.23 | 0.023 (0.005) | <0.001 |
BP, blood pressure; CAU, care as usual; cMetS z-score, continuous metabolic syndrome z-score; DBP, diastolic blood pressure; HDL, high-density lipoprotein; HOMA-IR, homeostatic model assessment for insulin resistance; LDL, low-density lipoprotein; SBP, systolic blood pressure; SMS−, lifestyle intervention without SMS support; SMS+, lifestyle intervention with SMS support; TG, triglyceride.
Statistically significant values (P<0.05) are presented in bold.
Changes in metabolic syndrome and metabolic parameters after changes in body weight for all groups combined (SMS+, SMS−, and CAU). Differences were tested with multilevel logistic regression analyses for categorical variables and with multilevel linear regression analyses for continuous variables, combined with a bootstrap procedure in case of a non-normal distribution.
. | Changes in body weight (all groups combined) . | ||||
---|---|---|---|---|---|
5% weight gain . | 5% weight loss . | 10% weight loss . | Estimate (s.e.) . | P value . | |
Metabolic syndrome (%) | 14.1 | −13.2 | −23.8 | 0.114 (0.028) | <0.001 |
Waist ≥ 88 cm (%) | 5.5 | −9.2 | −22.9 | 0.139 (0.033) | <0.001 |
Glucose ≥ 6.1 mmol/L (%) | 2.7 | −1.7 | −2.7 | 0.105 (0.061) | 0.090 |
BP ≥ 129/84 mmHg (%) | 6.9 | −6.1 | −11.4 | 0.061 (0.025) | 0.017 |
HDL < 1.3 mmol/L (%) | 1.4 | −1.9 | −4.4 | 0.066 (0.044) | 0.133 |
TG ≥ 1.7 mmol/L (%) | 5.5 | −4.9 | −9.0 | 0.054 (0.027) | 0.047 |
Insulin resistance (%) | 9.2 | −11.5 | −24.2 | 0.103 (0.025) | <0.001 |
Metabolic parameters | |||||
cMetS z-score | 0.22 | −0.22 | −0.43 | 0.043 (0.005) | <0.001 |
HOMA-IR | 0.42 | −0.42 | −0.83 | 0.083 (0.017) | <0.001 |
SBP (mmHg) | 2 | −2 | −4 | 0.373 (0.101) | 0.001 |
DBP (mmHg) | 2 | −2 | −3 | 0.333 (0.076) | <0.001 |
Waist (cm) | 4.1 | −4.1 | −8.3 | 0.827 (0.080) | <0.001 |
Glucose (mmol/L) | 0.1 | −0.1 | −0.2 | 0.015 (0.004) | 0.001 |
Insulin (pmol/L) | 11 | −11 | −22 | 2.187 (0.484) | <0.001 |
Cholesterol (mmol/L) | 0.1 | −0.1 | −0.2 | 0.022 (0.006) | 0.001 |
HDL (mmol/L) | −0.02 | 0.02 | 0.05 | −0.005 (0.002) | 0.006 |
LDL (mmol/L) | 0.08 | −0.08 | −0.17 | 0.017 (0.005) | 0.005 |
TG (mmol/L) | 0.12 | −0.12 | −0.23 | 0.023 (0.005) | <0.001 |
. | Changes in body weight (all groups combined) . | ||||
---|---|---|---|---|---|
5% weight gain . | 5% weight loss . | 10% weight loss . | Estimate (s.e.) . | P value . | |
Metabolic syndrome (%) | 14.1 | −13.2 | −23.8 | 0.114 (0.028) | <0.001 |
Waist ≥ 88 cm (%) | 5.5 | −9.2 | −22.9 | 0.139 (0.033) | <0.001 |
Glucose ≥ 6.1 mmol/L (%) | 2.7 | −1.7 | −2.7 | 0.105 (0.061) | 0.090 |
BP ≥ 129/84 mmHg (%) | 6.9 | −6.1 | −11.4 | 0.061 (0.025) | 0.017 |
HDL < 1.3 mmol/L (%) | 1.4 | −1.9 | −4.4 | 0.066 (0.044) | 0.133 |
TG ≥ 1.7 mmol/L (%) | 5.5 | −4.9 | −9.0 | 0.054 (0.027) | 0.047 |
Insulin resistance (%) | 9.2 | −11.5 | −24.2 | 0.103 (0.025) | <0.001 |
Metabolic parameters | |||||
cMetS z-score | 0.22 | −0.22 | −0.43 | 0.043 (0.005) | <0.001 |
HOMA-IR | 0.42 | −0.42 | −0.83 | 0.083 (0.017) | <0.001 |
SBP (mmHg) | 2 | −2 | −4 | 0.373 (0.101) | 0.001 |
DBP (mmHg) | 2 | −2 | −3 | 0.333 (0.076) | <0.001 |
Waist (cm) | 4.1 | −4.1 | −8.3 | 0.827 (0.080) | <0.001 |
Glucose (mmol/L) | 0.1 | −0.1 | −0.2 | 0.015 (0.004) | 0.001 |
Insulin (pmol/L) | 11 | −11 | −22 | 2.187 (0.484) | <0.001 |
Cholesterol (mmol/L) | 0.1 | −0.1 | −0.2 | 0.022 (0.006) | 0.001 |
HDL (mmol/L) | −0.02 | 0.02 | 0.05 | −0.005 (0.002) | 0.006 |
LDL (mmol/L) | 0.08 | −0.08 | −0.17 | 0.017 (0.005) | 0.005 |
TG (mmol/L) | 0.12 | −0.12 | −0.23 | 0.023 (0.005) | <0.001 |
BP, blood pressure; CAU, care as usual; cMetS z-score, continuous metabolic syndrome z-score; DBP, diastolic blood pressure; HDL, high-density lipoprotein; HOMA-IR, homeostatic model assessment for insulin resistance; LDL, low-density lipoprotein; SBP, systolic blood pressure; SMS−, lifestyle intervention without SMS support; SMS+, lifestyle intervention with SMS support; TG, triglyceride.
Statistically significant values (P<0.05) are presented in bold.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.